0,805  0,005  Antiprotozoal
0,789  0,004  Antiprotozoal (Plasmodium)
0,630  0,010  CYP2D6 substrate
0,534  0,013  Antiamyloidogenic
0,505  0,014  Amyloid beta aggregation inhibitor
0,491  0,003  Antiprotozoal (Trichomonas)
0,482  0,004  CYP2B6 inhibitor
0,508  0,044  TNF expression inhibitor
0,462  0,021  Antiprotozoal (Leishmania)
0,462  0,029  CYP1A2 substrate
0,450  0,038  Ulceration
0,454  0,078  Antineoplastic (solid tumors)
0,381  0,050  Aldehyde oxidase inhibitor
0,348  0,025  Antiarrhythmic
0,340  0,024  Muscle relaxant
0,299  0,011  Chelator
0,341  0,053  CYP2D6 inhibitor
0,277  0,008  Antiprotozoal (Amoeba)
0,303  0,038  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,315  0,051  Antiprotozoal (Trypanosoma)
0,316  0,056  Antineoplastic (multiple myeloma)
0,263  0,007  Antiviral (Ebola)
0,311  0,056  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,260  0,009  Dementia treatment
0,304  0,054  Cardiotonic
0,256  0,009  Vascular dementia treatment
0,330  0,089  CYP2C9 substrate
0,307  0,067  Antineoplastic (endocrine cancer)
0,243  0,004  Histamine N-methyltransferase inhibitor
0,272  0,036  Neuropeptide Y2 antagonist
0,262  0,030  Antianorexic
0,278  0,049  Ca2+/calmodulin-dependent protein kinase inhibitor
0,274  0,051  Antiparasitic
0,264  0,048  Antiparkinsonian, rigidity relieving
0,297  0,082  Antineoplastic (small cell lung cancer)
0,221  0,014  Antifungal (Cryptococcus)
0,234  0,031  Liver fibrosis treatment
0,272  0,069  Flavin-containing monooxygenase substrate
0,207  0,004  Botulinum neurotoxin type A inhibitor
0,212  0,015  Antischistosomal
0,296  0,102  CYP3A4 substrate
0,265  0,088  FMO3 substrate
0,213  0,037  MAO inhibitor
0,176  0,007  Antiprotozoal activity enhancer
0,268  0,101  CYP3A4 inhibitor
0,238  0,073  Cardiodepressant
0,328  0,165  Caspase 9 stimulant
0,226  0,063  Antialcoholic
0,245  0,084  Antineoplastic (bladder cancer)
0,196  0,040  ATPase inhibitor
0,290  0,135  CYP2C19 inhibitor
0,314  0,162  Apoptosis agonist
0,208  0,061  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,221  0,074  Antiulcerative
0,208  0,063  Antihelmintic
0,148  0,005  Potassium channel (ATP-sensitive) blocker
0,231  0,089  Antineoplastic (renal cancer)
0,218  0,080  Antiviral (West Nile virus)
0,161  0,024  Aldehyde dehydrogenase substrate
0,183  0,046  Skeletal muscle relaxant
0,198  0,062  Sigma receptor agonist
0,183  0,048  Antidote
0,212  0,085  Peptidyltransferase inhibitor
0,178  0,053  Acetylcholine M1 receptor antagonist
0,255  0,130  Vasodilator, coronary
0,169  0,047  Nav1.2 sodium channel blocker
0,259  0,137  Calcium channel activator
0,175  0,054  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,169  0,050  Antiprotozoal (Coccidial)
0,140  0,022  Telomerase inhibitor
0,134  0,016  Antifungal (Candida)
0,135  0,020  MAP-kinase-activated kinase inhibitor
0,223  0,108  Transcription factor STAT3 inhibitor
0,123  0,010  Protease activated receptor 1 antagonist
0,122  0,011  Elastase 1 inhibitor
0,127  0,017  MAP-kinase-activated kinase 2 inhibitor
0,131  0,021  Lanosterol 14 alpha demethylase inhibitor
0,145  0,039  Polo-like kinase-4 inhibitor
0,150  0,048  Nav1.3 sodium channel blocker
0,141  0,041  MAO B inhibitor
0,106  0,006  Heme oxygenase stimulant
0,207  0,110  Superoxide dismutase inhibitor
0,133  0,036  Myasthenia Gravis treatment
0,217  0,121  5 Hydroxytryptamine uptake stimulant
0,214  0,120  CYP1A2 inhibitor
0,209  0,120  Antituberculosic
0,124  0,035  Nitric-oxide synthase inhibitor
0,210  0,123  CYP2C19 substrate
0,128  0,041  Falcipain inhibitor
0,179  0,094  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,130  0,045  MAP kinase 9 inhibitor
0,144  0,061  Nav1.6 sodium channel blocker
0,156  0,074  Eye irritation, high
0,123  0,041  Falcipain 2 inhibitor
0,164  0,084  Toxic, respiratory center
0,197  0,118  DNA damaging
0,095  0,016  Protease activated receptor antagonist
0,221  0,145  Antineoplastic (lung cancer)
0,079  0,007  CC chemokine 4 receptor antagonist
0,105  0,039  NADH dehydrogenase inhibitor
0,182  0,117  Age-related macular degeneration treatment
0,175  0,111  Potassium channel blocker
0,080  0,017  Corticotropin releasing factor 2 receptor antagonist
0,197  0,135  Antineoplastic (colorectal cancer)
0,194  0,132  Antineoplastic (pancreatic cancer)
0,119  0,058  DNA intercalator
0,189  0,129  Spasmolytic
0,180  0,122  Antineoplastic (non-small cell lung cancer)
0,237  0,179  CYP2C9 inhibitor
0,113  0,055  Antiprotozoal (Toxoplasma)
0,176  0,118  Free radical scavenger
0,147  0,090  Antihelmintic (Nematodes)
0,202  0,148  Antimycobacterial
0,260  0,206  Alzheimer's disease treatment
0,186  0,134  Antineoplastic (ovarian cancer)
0,184  0,134  Antineoplastic (colon cancer)
0,159  0,109  Psychostimulant
0,208  0,158  Antileukemic
0,160  0,111  Interleukin antagonist
0,181  0,134  Calpain inhibitor
0,193  0,148  Transcription factor STAT inhibitor
0,150  0,106  Catenin beta inhibitor
0,103  0,059  Butyrylcholinesterase inhibitor
0,083  0,042  NMDA 2 receptor antagonist
0,161  0,124  Antineoplastic (glioma)
0,101  0,065  Gastric antisecretory
0,174  0,142  MAP-kinase-activated kinase 5 inhibitor
0,044  0,013  AMPA 2 receptor antagonist
0,129  0,099  Antiviral (Herpes)
0,253  0,224  5 Hydroxytryptamine release inhibitor
0,081  0,053  Acetylcholine nicotinic antagonist
0,174  0,147  Antineoplastic (melanoma)
0,062  0,035  Bcl-xL inhibitor
0,047  0,021  Plasmepsin II inhibitor
0,165  0,140  Acute neurologic disorders treatment
0,197  0,173  Ca2+/calmodulin-dependent kinase IV inhibitor
0,044  0,020  Factor XIIIa inhibitor
0,095  0,072  Nav1.1 sodium channel blocker
0,064  0,043  HIV-1 integrase (3'-Processing) inhibitor
0,076  0,055  Nicotinic alpha4beta2 receptor antagonist
0,091  0,070  MAO A inhibitor
0,181  0,160  Prostate cancer treatment
0,196  0,175  Angiogenesis inhibitor
0,095  0,075  Mediator release inhibitor
0,135  0,115  Sensitization
0,114  0,095  Toll-Like receptor antagonist
0,027  0,010  Elastase 2 inhibitor
0,027  0,010  Elastase 2A inhibitor
0,040  0,023  Potassium channel Kv1.1 blocker
0,039  0,023  Antiviral (Bovine viral diarrhea virus)
0,028  0,012  Corticotropin releasing factor 1 receptor antagonist
0,045  0,029  Geranyltranstransferase inhibitor
0,129  0,114  Carcinogenic
0,056  0,042  Glutamate (mGluR1) antagonist
0,105  0,091  Glutamate receptor antagonist
0,035  0,021  Glutamate (mGluR4) agonist
0,189  0,175  Insulysin inhibitor
0,125  0,112  Neuropeptide Y1 antagonist
0,131  0,120  LIM domain kinase 1 inhibitor
0,117  0,107  Mutagenic
0,094  0,084  Factor V inhibitor
0,041  0,031  Cathepsin F inhibitor
0,042  0,032  Glutamate (mGluR group III) agonist
0,014  0,007  Antineoplastic (insulinoma)
0,105  0,099  Cathepsin H inhibitor
0,116  0,111  Corneal wound healing stimulator
0,195  0,191  GST A substrate
0,090  0,086  Alpha 2b adrenoreceptor antagonist
0,149  0,145  Antineoplastic (lymphocytic leukemia)
0,102  0,098  CNS active muscle relaxant
0,102  0,098  Retinopathy treatment
0,026  0,023  Thrombin receptor antagonist
0,055  0,053  Potassium channel (Ca-activated) blocker
0,058  0,056  Neuronal nicotinic receptor antagonist
0,194  0,192  Antineoplastic (breast cancer)
0,052  0,050  Protein kinase C theta inhibitor
0,163  0,162  5 Hydroxytryptamine release stimulant
0,201  0,200  Histamine release inhibitor
0,031  0,031  Benzodiazepine receptor peripheral-type antagonist

